Hedge Fund - OrbiMed Advisors
Sinovac Biotech Ltd (SVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $340,000,000 | 6.79% | 2,718,735 | $ |
| 2 | 2023 - Q3 (2023-09-30) | $340,000,000 | 7.22% | 2,718,735 | $6.47 |
| 3 | 2023 - Q2 (2023-06-30) | $340,000,000 | 6.16% | 2,718,735 | $6.47 |
| 4 | 2023 - Q1 (2023-03-31) | $340,000,000 | 6.67% | 2,718,735 | $6.47 |
| 5 | 2022 - Q4 (2022-12-31) | $340,000,000 | 6.5% | 2,718,735 | $6.47 |
| 6 | 2022 - Q3 (2022-09-30) | $340,500,000 | 6.32% | 2,718,735 | $6.47 |
| 7 | 2022 - Q2 (2022-06-30) | $349,500,000 | 6.33% | 2,718,735 | $6.47 |
| 8 | 2022 - Q1 (2022-03-31) | $0 | 0% | 0 | $6.47 |
| 9 | 2021 - Q4 (2021-12-31) | $72,700,000 | 0.93% | 2,839,500 | $6.47 |
| 10 | 2021 - Q3 (2021-09-30) | $78,400,000 | 0.86% | 2,839,500 | $6.47 |
| 11 | 2021 - Q2 (2021-06-30) | $76,800,000 | 0.77% | 2,839,500 | $6.47 |
| 12 | 2021 - Q1 (2021-03-31) | $72,000,000 | 0.67% | 2,839,500 | $6.47 |
| 13 | 2020 - Q4 (2020-12-31) | $72,000,000 | 0.63% | 2,839,500 | $6.47 |
| 14 | 2020 - Q3 (2020-09-30) | $27,300,000 | 0.34% | 2,839,500 | $6.47 |
| 15 | 2020 - Q2 (2020-06-30) | $25,500,000 | 0.35% | 2,839,500 | $6.47 |
| 16 | 2020 - Q1 (2020-03-31) | $17,151,000 | 0.28% | 2,839,500 | $6.47 |
| 17 | 2019 - Q4 (2019-12-31) | $17,151,000 | 0.24% | 2,839,500 | $6.47 |
| 18 | 2019 - Q3 (2019-09-30) | $16,611,000 | 0.31% | 2,839,500 | $6.47 |
| 19 | 2019 - Q2 (2019-06-30) | $16,611,000 | 0.25% | 2,839,500 | $6.47 |
| 20 | 2019 - Q1 (2019-03-31) | $18,372,000 | 0.28% | 2,839,500 | $6.53 |
| 21 | 2018 - Q4 (2018-12-31) | $19,706,000 | 0.36% | 2,839,500 | $7.30 |
| 22 | 2018 - Q3 (2018-09-30) | $21,637,000 | 0.26% | 2,839,500 | $7.22 |
| 23 | 2018 - Q2 (2018-06-30) | $21,183,000 | 0.25% | 2,839,500 | $7.87 |
| 24 | 2018 - Q1 (2018-03-31) | $24,448,000 | 0.3% | 2,839,500 | $8.24 |
| 25 | 2017 - Q4 (2017-12-31) | $22,375,000 | 0.28% | 2,839,500 | $7.48 |
| 26 | 2017 - Q3 (2017-09-30) | $18,806,000 | 0.17% | 2,667,500 | $6.83 |
| 27 | 2017 - Q2 (2017-06-30) | $18,006,000 | 0.18% | 2,667,500 | $5.48 |
| 28 | 2017 - Q1 (2017-03-31) | $15,285,000 | 0.17% | 2,667,500 | $5.79 |
| 29 | 2016 - Q4 (2016-12-31) | $15,738,000 | 0.2% | 2,667,500 | $6.01 |
| 30 | 2016 - Q3 (2016-09-30) | $15,738,000 | 0.17% | 2,667,500 | $5.88 |
| 31 | 2016 - Q2 (2016-06-30) | $15,818,000 | 0.16% | 2,667,500 | $6.13 |
| 32 | 2016 - Q1 (2016-03-31) | $17,045,000 | 0.17% | 2,667,500 | $6.00 |
| 33 | 2015 - Q4 (2015-12-31) | $15,258,000 | 0.13% | 2,667,500 | $5.38 |
| 34 | 2015 - Q3 (2015-09-30) | $13,551,000 | 0.13% | 2,667,500 | $5.30 |
| 35 | 2015 - Q2 (2015-06-30) | $14,004,000 | 0.11% | 2,667,500 | $5.28 |
| 36 | 2015 - Q1 (2015-03-31) | $13,231,000 | 0.11% | 2,667,500 | $4.93 |
| 37 | 2014 - Q4 (2014-12-31) | $14,756,000 | 0.14% | 2,821,500 | $5.10 |
| 38 | 2014 - Q3 (2014-09-30) | $13,571,000 | 0.14% | 2,821,500 | $5.37 |
| 39 | 2014 - Q2 (2014-06-30) | $9,236,000 | 0.1% | 1,637,500 | $6.07 |
| 40 | 2014 - Q1 (2014-03-31) | $11,790,000 | 0.14% | 1,637,500 | $6.62 |
| 41 | 2013 - Q4 (2013-12-31) | $10,022,000 | 0.14% | 1,637,500 | $6.03 |
| 42 | 2013 - Q3 (2013-09-30) | $11,268,000 | 0.2% | 1,884,200 | $4.78 |
| 43 | 2013 - Q2 (2013-06-30) | $7,405,000 | 0.15% | 1,884,200 | $3.72 |
| 44 | 2013 - Q1 (2013-03-31) | $7,766,000 | 0.18% | 2,087,700 | $3.39 |
| 45 | 2012 - Q4 (2012-12-31) | $716,000 | 0.02% | 228,000 | $2.84 |
| 46 | 2012 - Q3 (2012-09-30) | $0 | 0% | 0 | $2.25 |
| 47 | 2012 - Q1 (2012-03-31) | $508,000 | 0.01% | 249,000 | $2.15 |
| 48 | 2011 - Q4 (2011-12-31) | $548,000 | 0.01% | 249,000 | $2.22 |
The displayed share prices are average quarterly stock market prices.